Sophie Rivière Selected Research

Sophie Rivière Research Topics

Disease

4	Epistaxis (Nosebleed) 04/2020 - 03/2012
4	Hereditary Hemorrhagic Telangiectasia 04/2020 - 03/2012
4	Neoplasms (Cancer) 03/2020 - 08/2012
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2020 - 01/2018
3	Uveitis 01/2020 - 06/2017
2	Inflammation (Inflammations) 03/2020 - 11/2014
2	Syphilis 01/2020 - 06/2017
2	Infections 02/2018 - 09/2013
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2018 - 12/2010
2	Microscopic Polyangiitis 01/2018 - 12/2010
1	Hyperhomocysteinemia 01/2022
1	Fatigue 01/2022
1	Acute Intermittent Porphyria (Porphyria, Acute) 01/2022
1	Nausea 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Injection Site Reaction 01/2022
1	Sarcoidosis (Schaumann Disease) 04/2018
1	Tuberculosis (Tuberculoses) 04/2018
1	Virus Diseases (Viral Diseases) 04/2018
1	Opportunistic Infections (Opportunistic Infection) 02/2018
1	Coinfection 02/2018
1	Hematologic Diseases (Blood Diseases) 02/2018
1	Hematologic Neoplasms (Hematological Malignancy) 02/2018
1	Autoimmune Diseases (Autoimmune Disease) 02/2018
1	Pathologic Complete Response 01/2018
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Capillary Leak Syndrome 10/2017
1	Paraproteinemias (Monoclonal Gammopathy) 10/2017
1	Vasculitis (Vasculitides) 11/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2015
1	Cytokine Release Syndrome 11/2014
1	Adult-Onset Still's Disease 11/2014
1	High Cardiac Output 03/2012
1	Heart Failure 03/2012
1	Vascular Malformations 03/2012
1	Abdominal Pain (Pain, Abdominal) 06/2002

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 10/2020 - 01/2018
4	Bevacizumab (Avastin)FDA Link 01/2017 - 03/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2015
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2020 - 11/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2020 - 03/2020
2	AutoantibodiesIBA 03/2020 - 01/2018
2	C-Reactive ProteinIBA 01/2020 - 06/2017
2	Tuberculin (PPD)IBA 01/2020 - 06/2017
2	Monoclonal AntibodiesIBA 01/2017 - 01/2016
1	HomocysteineIBA 01/2022
1	Aminolevulinic Acid (Levulan)FDA Link 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Heme (Haem)IBA 01/2022
1	givosiranIBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2020
1	Ointments (Pastes)IBA 04/2020
1	AntibodiesIBA 03/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2018
1	SteroidsIBA 02/2018
1	Biological ProductsIBA 01/2018
1	RNA Polymerase IIIIBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2017
1	Immunoglobulin G (IgG)IBA 10/2017
1	Nasal SpraysIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 11/2014
1	CytokinesIBA 11/2014
1	Interleukin-18 (Interleukin 18)IBA 11/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2010

Therapy/Procedure

4	Therapeutics 10/2020 - 08/2012
1	Precision Medicine 01/2022
1	Aftercare (After-Treatment) 04/2020
1	Neoadjuvant Therapy 01/2018
1	Biological Therapy 11/2014
1	Liver Transplantation 03/2012
1	Tubal Sterilization (Tubal Ligation) 06/2002
1	Surgical Instruments (Clip) 06/2002